Chairman and CEO Liang Wenqing increased his holdings of Changfeng Pharmaceutical (02652) by 193,000 shares at a price of approximately HK$6.92 per share

Zhitongcaijing · 1d ago

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on October 6, Chairman and CEO Leung Man-ching increased his holdings of Changfeng Pharmaceutical (02652) by 193,000 shares, at a price of HK$6.9216 per share, for a total amount of about HK$133,600. The latest number of shares held after the increase was approximately 607.16,500 shares, with a shareholding ratio of 18.74%.

Additional Information: Acting to Acting in Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. As such, under the SFO, each of Dr. LIANG and Dr. LI LI BOVET is considered to be considered in the Shares the other is considered in.